PATENT CLAIM ANALYSIS

Application Number: 16127509
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "021900"]

Abstract:
The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist or caspase inhibitor and another therapeutic agent, e.g. PPAR-delta agonist in particular for treating or preventing liver diseases or disorders.

Claim (Index 10):
Combination according to  claim 1  which is a fixed dose combination.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16335662', '15612124', '15263033', '15598734', '15551224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7661882965270509
- 35 USC 102 Novelty (BERT): 0.5191868653958988
- Combined Prediction Score: 0.7414881534139357
- Mean Citation Score: 232.16857200000004
- Max Citation Score: 309.541
- Similarity Product: 227.6750923942924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test